Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era.
Patrice CacoubMathieu VautierAnne Claire DesboisAntoine LafumaDavid SaadounPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
Improved antiviral efficacy of HCV drugs in the DAA era led to increased clinical and immunological efficacy and a lower death rate. Use of DAAs was associated to higher costs for HCV drugs while costs related to both hospitalizations and non-antiviral treatments decreased.